These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15749317)

  • 1. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
    Mastoraki E; Michalopoulos A; Kriaras I; Mouchtouri E; Falagas ME; Karatza D; Geroulanos S
    J Infect; 2008 Jan; 56(1):35-9. PubMed ID: 17983660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3960-4. PubMed ID: 19853540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery.
    Mastoraki S; Michalopoulos A; Kriaras I; Geroulanos S
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):442-6. PubMed ID: 17669893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.
    Bertholee D; ter Horst PG; Hijmering ML; Spanjersberg AJ; Hospes W; Wilffert B
    Int J Clin Pharm; 2013 Oct; 35(5):798-804. PubMed ID: 23794078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
    Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.
    Wiesner G; Braun SL; Gruber M; Gertler R; Lange R; Tassani P; Martin K
    J Antimicrob Chemother; 2012 Jan; 67(1):230-3. PubMed ID: 21972268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
    Vuorisalo S; Pokela R; Syrjälä H
    J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single-dose ceftriaxone versus multiple-dose cefuroxime for prophylaxis of surgical site infection].
    Li ZL; Tong SX; Yu BM; Tang WS; Wu ZY; Wang SB; Wu YF; Lu WQ; Luo M; Wang J
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):372-4. PubMed ID: 12892594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose intravenous regional antibiotic in clean orthopaedic procedures.
    Khan ML; Ahmed S; Haque A; Ahamed S; Mosabber M; Awal A; Ahmed I
    Bangladesh Med Res Counc Bull; 2002 Aug; 28(2):70-6. PubMed ID: 12825764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
    Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.
    Skhirtladze-Dworschak K; Hutschala D; Reining G; Dittrich P; Bartunek A; Dworschak M; Tschernko EM
    Br J Clin Pharmacol; 2019 Apr; 85(4):818-826. PubMed ID: 30636060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
    Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cefazolin levels during cardiovascular surgery: effects of cardiopulmonary bypass and profound hypothermic circulatory arrest.
    Caffarelli AD; Holden JP; Baron EJ; Lemmens HJ; D'Souza H; Yau V; Olcott C; Reitz BA; Miller DC; van der Starre PJ
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1338-43. PubMed ID: 16733167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.
    Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A
    Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of surgical antimicrobial prophylaxis.
    Weber WP; Marti WR; Zwahlen M; Misteli H; Rosenthal R; Reck S; Fueglistaler P; Bolli M; Trampuz A; Oertli D; Widmer AF
    Ann Surg; 2008 Jun; 247(6):918-26. PubMed ID: 18520217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing antimicrobial prophylaxis in reconstructive vascular surgery.
    Voesten HG; Degener JE; Dijkstra PK; van der Goot L; Agema A; Sikkema B; van der Meer AL
    Vasa; 1993; 22(4):342-6. PubMed ID: 8310774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.